Skip to main content

Table 1 Correlations between CTHRC1 levels in ESCC tissues and clinicopathological characteristics of patients with ESCC

From: High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation

Characteristic

 

CTHRC1 expression

P

Low

High

Age

≤60

49

67

0.128

>60

28

60

Gender

Male

62

106

0.593

Female

15

21

Tobacco use

No

27

45

0.957

Yes

50

82

Alcohol use

No

30

46

0.695

Yes

47

81

Family history

No

65

106

0.858

Yes

12

21

Location

Upper/Middle

39

60

0.637

Lower

38

67

Histology grade

G1/G2

59

94

0.677

G3

18

33

T stage

T1/T2/T3

44

54

0.043

T4

33

73

Lymph node metastasis

No

49

60

0.023

Yes

28

67

TNM stage

I/II

39

44

0.024

III

38

83

FRA-1

Low

22

28

0.116

High

45

97

Snail1

Low

39

53

0.100

High

33

73

MMP14

Low

45

58

0.022

High

26

67

Cyclin D1

Low

53

66

0.018

High

24

61

  1. χ 2test was used. P value was italicized when P < 0.05
  2. CTHRC1 Collagen triple helix repeat containing-1 (CTHRC1); FRA-1 Fos-related antigen 1